Cargando…

Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

PURPOSE: The purpose of this study was to evaluate the diagnostic value of soluble Axl (sAxl) in hepatocellular carcinoma (HCC) in comparison with serum α-fetoprotein (AFP). MATERIALS AND METHODS: Eighty HCC patients, 80 liver cirrhosis patients (LC), 80 patients with hepatitis B virus (HBV) infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xiaoting, Wu, Ailu, Ding, Zhixiao, Liang, Shixiong, Zhang, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373855/ https://www.ncbi.nlm.nih.gov/pubmed/32138467 http://dx.doi.org/10.4143/crt.2019.749

Ejemplares similares

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
por: Dengler, Mirko, et al.
Publicado: (2017)

Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
por: Qi, Peng, et al.
Publicado: (2011)

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
por: Van Hees, Stijn, et al.
Publicado: (2016)

Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
por: Johansson, Gunnar, et al.
Publicado: (2014)

The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
por: Staufer, Katharina, et al.
Publicado: (2017)

Soluble AXL as a marker of disease progression and survival in melanoma
por: Flem-Karlsen, Karine, et al.
Publicado: (2020)

Correction: Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Publicado: (2015)

Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture
por: Xu, Jing, et al.
Publicado: (2015)

High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation
por: Mirabet, Sonia, et al.
Publicado: (2018)

Bioluminescent RAPPID Sensors for the Single-Step Detection of Soluble Axl and Multiplex Analysis of Cell Surface Cancer Biomarkers
por: van Aalen, Eva A., et al.
Publicado: (2022)

Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response
por: Read, Scott A., et al.
Publicado: (2015)

Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
por: Holstein, Elisa, et al.
Publicado: (2018)

Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma
por: Fouad, Shawky A, et al.
Publicado: (2014)

Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma
por: Zhu, Kai, et al.
Publicado: (2020)

Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2019)

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
por: Ye, Fei, et al.
Publicado: (2021)

Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype
por: Gui, Shunping, et al.
Publicado: (2021)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
por: Deng, Huan, et al.
Publicado: (2020)

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
por: Wei, Xiao-yu, et al.
Publicado: (2020)

Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis
por: Liu, Tianhua, et al.
Publicado: (2017)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection
por: Li, Fang, et al.
Publicado: (2018)

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
por: Martínez-Bosch, Neus, et al.
Publicado: (2021)

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
por: Huang, Jian-Lv, et al.
Publicado: (2021)

Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
por: Pandyarajan, Vijay, et al.
Publicado: (2021)

Transition of Antibody to Hepatitis C Virus from Chronic Hepatitis to Hepatocellular Carcinoma
por: Kiyosawa, Kendo, et al.
Publicado: (1990)

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients
por: Elkammah, Maha, et al.
Publicado: (2021)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
por: Noverati, Nicholas, et al.
Publicado: (2022)

Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection
por: Chan, Kelvin Yuen-Kwong, et al.
Publicado: (2011)

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population
por: Ma, Ning, et al.
Publicado: (2023)

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection
por: Li, Na, et al.
Publicado: (2017)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Axl is not an indispensable factor for Zika virus infection in mice
por: Wang, Zhao-Yang, et al.
Publicado: (2017)

AXL is not essential for Zika virus infection in the mouse brain
por: Li, Feng, et al.
Publicado: (2017)

Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
por: Haider, Christine, et al.
Publicado: (2018)

AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma
por: Chai, Zong-Tao, et al.
Publicado: (2021)

Faults Diagnostics of Railway Axle Bearings Based on IMF’s Confidence Index Algorithm for Ensemble EMD
por: Yi, Cai, et al.
Publicado: (2015)

Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
por: Yao, Mingjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tf3a6okfsrdj3p8b97foh0moe5